MICROBIOLOGICAL ACTIVITIES OF LYSOSTAPHIN AND PENICILLINS AGAINST BACTERIOPHAGE 80/81 STRAINS OF STAPHYLOCOCCUS AUREUS.
Using 20 clinical isolates of S. aureus (all bacteriophage 80/81 type), we found that lysostaphin inhibits the growth of all cultures at concentrations significantly lower than those observed with any of eight penicillins, a penicillin-like compound (cephalothin), or fusidic acid (a steroid antibiotic). All test cultures were shown to be resistant to penicillin G, ampicillin, and propicillin. Of the remaining penicillins (all penicillinase-insensitive), oxacillin, nafcillin, cloxacillin, and cephalothin were approximately equal in antimicrobial activity. Ancillin was slightly less active, and methicillin was even lower in potency. Cultures varied more widely in susceptibility to fusidic acid. None of the clinical isolates tested was found to be resistant to lysostaphin.
D000667:Ampicillin; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001434:Bacteriophage Typing; D002512:Cephalothin; D003023:Cloxacillin; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005672:Fusidic Acid; D006801:Humans; D008248:Lysostaphin; D008712:Methicillin; D010068:Oxacillin; D010400:Penicillin G; D010405:Penicillinase; D010406:Penicillins; D012106:Research; D013210:Staphylococcus; D013204:Staphylococcus Phages; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D010406:Penicillins; D005672:Fusidic Acid; D000667:Ampicillin; D008248:Lysostaphin; D010405:Penicillinase; D003023:Cloxacillin; D010400:Penicillin G; D008712:Methicillin; D002512:Cephalothin; D010068:Oxacillin
ANTIBIOTICS; BACTERIOPHAGE TYPING; CEPHALOTHIN; DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; FUSIDIC ACID; LYSOSTAPHIN; PENICILLIN; PENICILLINASE; STAPHYLOCOCCAL PHAGES; STAPHYLOCOCCUS